Cargando…
Immunological Deregulation in Classic Hodgkin Lymphoma
Classic Hodgkin Lymphoma (cHL) has a unique histology since only a few neoplastic cells are surrounded by inflammatory accessory cells that in the last years have emerged as crucial players in sustaining the course of disease. In addition, recent studies suggest that the abnormal activity of these i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063611/ https://www.ncbi.nlm.nih.gov/pubmed/24959336 http://dx.doi.org/10.4084/MJHID.2014.039 |
_version_ | 1782321820754509824 |
---|---|
author | Romano, Alessandra Vetro, Calogero Caocci, Giovanni Greco, Marianna Parrinello, Nunziatina Laura Di Raimondo, Francesco La Nasa, Giorgio |
author_facet | Romano, Alessandra Vetro, Calogero Caocci, Giovanni Greco, Marianna Parrinello, Nunziatina Laura Di Raimondo, Francesco La Nasa, Giorgio |
author_sort | Romano, Alessandra |
collection | PubMed |
description | Classic Hodgkin Lymphoma (cHL) has a unique histology since only a few neoplastic cells are surrounded by inflammatory accessory cells that in the last years have emerged as crucial players in sustaining the course of disease. In addition, recent studies suggest that the abnormal activity of these inflammatory cells (such as deregulation in regulatory T cells signaling, expansion of myeloid derived suppressor cells, HLA-G signaling and natural killer cells dysfunction) may have prognostic significance. This review is focused on summarizing recent advanced in immunological defects in cHL with translational implications. |
format | Online Article Text |
id | pubmed-4063611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Università Cattolica del Sacro Cuore |
record_format | MEDLINE/PubMed |
spelling | pubmed-40636112014-06-23 Immunological Deregulation in Classic Hodgkin Lymphoma Romano, Alessandra Vetro, Calogero Caocci, Giovanni Greco, Marianna Parrinello, Nunziatina Laura Di Raimondo, Francesco La Nasa, Giorgio Mediterr J Hematol Infect Dis Review Article Classic Hodgkin Lymphoma (cHL) has a unique histology since only a few neoplastic cells are surrounded by inflammatory accessory cells that in the last years have emerged as crucial players in sustaining the course of disease. In addition, recent studies suggest that the abnormal activity of these inflammatory cells (such as deregulation in regulatory T cells signaling, expansion of myeloid derived suppressor cells, HLA-G signaling and natural killer cells dysfunction) may have prognostic significance. This review is focused on summarizing recent advanced in immunological defects in cHL with translational implications. Università Cattolica del Sacro Cuore 2014-06-01 /pmc/articles/PMC4063611/ /pubmed/24959336 http://dx.doi.org/10.4084/MJHID.2014.039 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Romano, Alessandra Vetro, Calogero Caocci, Giovanni Greco, Marianna Parrinello, Nunziatina Laura Di Raimondo, Francesco La Nasa, Giorgio Immunological Deregulation in Classic Hodgkin Lymphoma |
title | Immunological Deregulation in Classic Hodgkin Lymphoma |
title_full | Immunological Deregulation in Classic Hodgkin Lymphoma |
title_fullStr | Immunological Deregulation in Classic Hodgkin Lymphoma |
title_full_unstemmed | Immunological Deregulation in Classic Hodgkin Lymphoma |
title_short | Immunological Deregulation in Classic Hodgkin Lymphoma |
title_sort | immunological deregulation in classic hodgkin lymphoma |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063611/ https://www.ncbi.nlm.nih.gov/pubmed/24959336 http://dx.doi.org/10.4084/MJHID.2014.039 |
work_keys_str_mv | AT romanoalessandra immunologicalderegulationinclassichodgkinlymphoma AT vetrocalogero immunologicalderegulationinclassichodgkinlymphoma AT caoccigiovanni immunologicalderegulationinclassichodgkinlymphoma AT grecomarianna immunologicalderegulationinclassichodgkinlymphoma AT parrinellonunziatinalaura immunologicalderegulationinclassichodgkinlymphoma AT diraimondofrancesco immunologicalderegulationinclassichodgkinlymphoma AT lanasagiorgio immunologicalderegulationinclassichodgkinlymphoma |